These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25263997)

  • 41. Treatment optimization in MS: Canadian MS Working Group updated recommendations.
    Freedman MS; Selchen D; Arnold DL; Prat A; Banwell B; Yeung M; Morgenthau D; Lapierre Y;
    Can J Neurol Sci; 2013 May; 40(3):307-23. PubMed ID: 23603165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain health: time matters in multiple sclerosis.
    Giovannoni G; Butzkueven H; Dhib-Jalbut S; Hobart J; Kobelt G; Pepper G; Sormani MP; Thalheim C; Traboulsee A; Vollmer T
    Mult Scler Relat Disord; 2016 Sep; 9 Suppl 1():S5-S48. PubMed ID: 27640924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done!
    Peeters LM; van Munster CE; Van Wijmeersch B; Bruyndonckx R; Lamers I; Hellings N; Popescu V; Thalheim C; Feys P
    Mult Scler; 2019 Apr; 25(4):500-509. PubMed ID: 30381984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individualizing treatment goals and interventions for people with MS.
    Giovannoni G; Rhoades RW
    Curr Opin Neurol; 2012 Feb; 25 Suppl():S20-7. PubMed ID: 22398661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Towards a Precision Medicine Approach Based on Machine Learning for Tailoring Medical Treatment in Alkaptonuria.
    Spiga O; Cicaloni V; Visibelli A; Davoli A; Paparo MA; Orlandini M; Vecchi B; Santucci A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis.
    Capkun G; Lahoz R; Verdun E; Song X; Chen W; Korn JR; Dahlke F; Freitas R; Fraeman K; Simeone J; Johnson BH; Nordstrom B
    Curr Med Res Opin; 2015 May; 31(5):1029-39. PubMed ID: 25661016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility of Real Time Internet-Based Teleconsultation in Patients With Multiple Sclerosis: Interventional Pilot Study.
    D'Haeseleer M; Eelen P; Sadeghi N; D'Hooghe MB; Van Schependom J; Nagels G
    J Med Internet Res; 2020 Aug; 22(8):e18178. PubMed ID: 32447274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.
    Boyko A; Therapontos C; Horakova D; Szilasiová J; Kalniņa J; Kolontareva J; Gross-Paju K; Selmaj K; Sereike I; Milo R; Gabelić T; Rot U
    Mult Scler Relat Disord; 2021 May; 50():102778. PubMed ID: 33592384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment optimization in multiple sclerosis.
    Freedman MS; Patry DG; Grand'Maison F; Myles ML; Paty DW; Selchen DH;
    Can J Neurol Sci; 2004 May; 31(2):157-68. PubMed ID: 15198439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic burden of multiple sclerosis and the role of managed sare organizations in multiple sclerosis management.
    Owens GM
    Am J Manag Care; 2016 Jun; 22(6 Suppl):s151-8. PubMed ID: 27356024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health promotion in people with multiple sclerosis.
    Bombardier CH; Wadhwani R; LaRotonda C
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):557-70. PubMed ID: 15893686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment decisions in multiple sclerosis - insights from real-world observational studies.
    Trojano M; Tintore M; Montalban X; Hillert J; Kalincik T; Iaffaldano P; Spelman T; Sormani MP; Butzkueven H
    Nat Rev Neurol; 2017 Feb; 13(2):105-118. PubMed ID: 28084327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Media, politics and science policy: MS and evidence from the CCSVI Trenches".
    Pullman D; Zarzeczny A; Picard A
    BMC Med Ethics; 2013 Feb; 14():6. PubMed ID: 23402260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple sclerosis: individualized disease susceptibility and therapy response.
    Pravica V; Markovic M; Cupic M; Savic E; Popadic D; Drulovic J; Mostarica-Stojkovic M
    Biomark Med; 2013 Feb; 7(1):59-71. PubMed ID: 23387485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Turning Feed-forward and Feedback Processes on Patient-reported Data into Intelligent Action and Informed Decision-making: Case Studies and Principles.
    Oliver BJ; Nelson EC; Kerrigan CL
    Med Care; 2019 May; 57 Suppl 5 Suppl 1():S31-S37. PubMed ID: 30985594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.
    Parkinson A; Drew J; Hall Dykgraaf S; Fanning V; Chisholm K; Elisha M; Lueck C; Phillips C; Desborough J
    Health Expect; 2021 Oct; 24(5):1607-1617. PubMed ID: 34227728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.
    Al Tahan AM; Alsharoqi I; Bohlega SA; Dahdaleh M; Daif A; Deleu D; Esmat K; Giampaolo D; Freedman MS; Gwilt M; Hosny H; Inshasi JS; Aljumah M; Khalifa A; Pakdaman H; Szólics M; Yamout BI; Sahraian MA; Zakaria MF
    Int J Neurosci; 2014 Sep; 124(9):635-41. PubMed ID: 24228830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
    Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E;
    J Clin Neurosci; 2014 Nov; 21(11):1857-65. PubMed ID: 24993136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M
    Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.